Aerovate Therapeutics Publishes Results of Phase 1 Study Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension in ERJ Open Research

Source: Nasdaq GlobeNewswire / 17 Nov 2022 07:45:00   America/New_York